The National Diabetic Retinopathy Laser Treatment Audit is a prospecti
ve survey of laser treatment for diabetic retinopathy throughout the U
nited Kingdom. This paper presents data on 284 patients who were under
going their first panretinal photocoagulation for proliferative retino
pathy during a 2 month period in 1995, describing the demographic feat
ures, the level of systematic screening, the sources of referral, and
the waiting times. For those cases where proliferative retinopathy was
present at the first ophthalmology outpatient visit, the retinopathy
was detected as a result of systematic screening in 46.8%, whilst 28.7
% presented symptomatically. Of these patients 28.4% waited for more t
han 12 weeks from referral to the time of laser treatment, but once th
e patient had been listed for laser treatment this was performed withi
n 8 weeks in 95.3%. The retinopathy features and the type of treatment
given are also described. Compared with the DRS and ETDRS recommendat
ions, at least 32.5-40.2% of eyes may be undertreated initially, and f
or those with highrisk characteristics these figures were at least 30.
8-38.5%.